FAC Explorer

Finding 1150674 (2021-002)

Material Weakness
Requirement
C
Questioned Costs
-
Year
2021
Accepted
2025-08-22
Audit: 364763
Organization: South Central Medical and Resource Center, Inc. (OK)
Auditor: Johnston and Bryant Certified Public Accountants

AI Summary

  • Answer: Implement written accounting procedures for accounts receivable.
  • Trend: Monthly reconciliation of the accounts receivable subsidiary ledger with the general ledger is essential.
  • List: Train staff on performing and documenting these reconciliations.

Finding Text

We recommend that the organization implement written accounting procedures that include maintaining an accounts receivable subsidiary ledger and reconciling it to the general ledger on a monthly basis. Staff responsible for accounts receivable should be trained to perform and document these reconciliations.

Categories

No categories assigned yet.

Other Findings in this Audit

  • 574199 2021-001
    Material Weakness
  • 574200 2021-002
    Material Weakness
  • 574201 2021-003
    Significant Deficiency
  • 574202 2021-004
    Material Weakness
  • 574203 2021-005
    Significant Deficiency
  • 574204 2021-006
    Significant Deficiency
  • 574205 2021-007
    Significant Deficiency
  • 574206 2021-008
    Significant Deficiency
  • 574207 2021-009
    Material Weakness
  • 574208 2021-010
    Material Weakness
  • 574209 2021-011
    Material Weakness
  • 574210 2021-012
    Material Weakness
  • 574211 2021-013
    Material Weakness
  • 574212 2021-014
    Material Weakness
  • 574213 2021-015
    Material Weakness
  • 574214 2021-016
    Material Weakness
  • 574215 2021-001
    Material Weakness
  • 574216 2021-002
    Material Weakness
  • 574217 2021-003
    Significant Deficiency
  • 574218 2021-004
    Material Weakness
  • 574219 2021-005
    Significant Deficiency
  • 574220 2021-006
    Significant Deficiency
  • 574221 2021-007
    Significant Deficiency
  • 574222 2021-008
    Significant Deficiency
  • 574223 2021-009
    Material Weakness
  • 574224 2021-010
    Material Weakness
  • 574225 2021-011
    Material Weakness
  • 574226 2021-012
    Material Weakness
  • 574227 2021-013
    Material Weakness
  • 574228 2021-014
    Material Weakness
  • 574229 2021-015
    Material Weakness
  • 574230 2021-016
    Material Weakness
  • 574231 2021-001
    Material Weakness
  • 574232 2021-002
    Material Weakness
  • 574233 2021-003
    Significant Deficiency
  • 574234 2021-004
    Material Weakness
  • 574235 2021-005
    Significant Deficiency
  • 574236 2021-006
    Significant Deficiency
  • 574237 2021-007
    Significant Deficiency
  • 574238 2021-008
    Significant Deficiency
  • 574239 2021-009
    Material Weakness
  • 574240 2021-010
    Material Weakness
  • 574241 2021-011
    Material Weakness
  • 574242 2021-012
    Material Weakness
  • 574243 2021-013
    Material Weakness
  • 574244 2021-014
    Material Weakness
  • 574245 2021-015
    Material Weakness
  • 574246 2021-016
    Material Weakness
  • 1150641 2021-001
    Material Weakness
  • 1150642 2021-002
    Material Weakness
  • 1150643 2021-003
    Significant Deficiency
  • 1150644 2021-004
    Material Weakness
  • 1150645 2021-005
    Significant Deficiency
  • 1150646 2021-006
    Significant Deficiency
  • 1150647 2021-007
    Significant Deficiency
  • 1150648 2021-008
    Significant Deficiency
  • 1150649 2021-009
    Material Weakness
  • 1150650 2021-010
    Material Weakness
  • 1150651 2021-011
    Material Weakness
  • 1150652 2021-012
    Material Weakness
  • 1150653 2021-013
    Material Weakness
  • 1150654 2021-014
    Material Weakness
  • 1150655 2021-015
    Material Weakness
  • 1150656 2021-016
    Material Weakness
  • 1150657 2021-001
    Material Weakness
  • 1150658 2021-002
    Material Weakness
  • 1150659 2021-003
    Significant Deficiency
  • 1150660 2021-004
    Material Weakness
  • 1150661 2021-005
    Significant Deficiency
  • 1150662 2021-006
    Significant Deficiency
  • 1150663 2021-007
    Significant Deficiency
  • 1150664 2021-008
    Significant Deficiency
  • 1150665 2021-009
    Material Weakness
  • 1150666 2021-010
    Material Weakness
  • 1150667 2021-011
    Material Weakness
  • 1150668 2021-012
    Material Weakness
  • 1150669 2021-013
    Material Weakness
  • 1150670 2021-014
    Material Weakness
  • 1150671 2021-015
    Material Weakness
  • 1150672 2021-016
    Material Weakness
  • 1150673 2021-001
    Material Weakness
  • 1150675 2021-003
    Significant Deficiency
  • 1150676 2021-004
    Material Weakness
  • 1150677 2021-005
    Significant Deficiency
  • 1150678 2021-006
    Significant Deficiency
  • 1150679 2021-007
    Significant Deficiency
  • 1150680 2021-008
    Significant Deficiency
  • 1150681 2021-009
    Material Weakness
  • 1150682 2021-010
    Material Weakness
  • 1150683 2021-011
    Material Weakness
  • 1150684 2021-012
    Material Weakness
  • 1150685 2021-013
    Material Weakness
  • 1150686 2021-014
    Material Weakness
  • 1150687 2021-015
    Material Weakness
  • 1150688 2021-016
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $445,622
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $166,795